![]() |
市场调查报告书
商品编码
1913446
法尼烯市场机会、成长要素、产业趋势分析及预测(2026年至2035年)Farnesene Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035 |
||||||
全球法尼烯市场预计到 2025 年将达到 1.803 亿美元,到 2035 年将达到 11 亿美元,年复合成长率为 19.9%。

由于法尼烯在众多产业的广泛应用,其市场正经历快速成长。法尼烯是一种天然存在的倍半萜烃,主要来自可再生原料,与全球转型为环境友善和永续材料的趋势高度契合。工业价值链中对天然原料日益增长的需求推动了法尼烯的广泛应用。法尼烯天然的芳香特性使其成为香料、食品添加物和药物製剂的重要成分。其抗氧化和抗菌特性进一步促进了其在个人保健产品和化妆品配方中的应用,增强了产品的稳定性和功能性。消费者对可再生和可生物降解原料的偏好不断增长,也持续推动市场成长。作为永续材料和生物基替代品(包括清洁剂)的建构模组,法尼烯在工业配方中的需求也不断扩大。其在治疗化合物合成中的药物应用不断拓展,进一步提升了其在全球市场的商业性潜力。
| 市场覆盖范围 | |
|---|---|
| 开始年份 | 2025 |
| 预测年份 | 2026-2035 |
| 起始值 | 1.803亿美元 |
| 预测金额 | 11亿美元 |
| 复合年增长率 | 19.9% |
2025年,β-法尼烯市占率达到80.1%,预计到2035年将以20%的复合年增长率成长。其强劲的市场地位得益于其天然来源、可生物降解性以及与永续病虫害防治实践的兼容性,使其在农业领域的应用日益广泛。此外,工业界对生物基替代品的需求不断增长,以减少对合成化学品的依赖,同时,持续的研究也拓展其在香精香料和能源相关领域的应用。
预计到 2025 年,以发酵为基础的生产方式将占据 85.2% 的市场份额,并在 2026 年至 2035 年期间以 19.9% 的复合年增长率增长。这种生产方式之所以受到青睐,是因为它能够高效利用可再生原料生产适用于高端应用的高纯度法尼烯,并且与生物技术主导的生产工艺相契合,有助于减少对石化燃料的依赖,并满足多个终端用户行业对天然级原料的需求。
预计到2025年,北美法尼烯市占率将达到27.2%。在监管压力和消费者对环保产品需求的推动下,个人护理和工业应用领域对永续原材料的日益普及,正推动该地区的市场扩张。先进的研发能力和生物基化学品製造领域的创新也进一步促进了市场发展。
The Global Farnesene Market was valued at USD 180.3 million in 2025 and is estimated to grow at a CAGR of 19.9% to reach USD 1.1 billion by 2035.

The market is experiencing rapid expansion due to rising adoption across a wide range of industries. Farnesene is a naturally occurring sesquiterpene hydrocarbon derived primarily from renewable feedstocks, which aligns strongly with the global shift toward environmentally responsible and sustainable materials. Its growing acceptance is supported by increasing demand for naturally sourced ingredients across industrial value chains. Farnesene plays an essential role as a raw material in fragrance, flavor, and pharmaceutical formulations due to its naturally appealing aromatic profile. Its antioxidant and antimicrobial properties further support its use in personal care and cosmetic formulations by enhancing product stability and functional performance. Rising consumer preference for renewable and biodegradable ingredients continues to support market growth. Farnesene is also gaining momentum as a building block for bio-based alternatives used in industrial formulations, including sustainable materials and cleaning solutions. Expanding pharmaceutical applications for synthesizing therapeutic compounds are further broadening their commercial potential across global markets.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $180.3 Million |
| Forecast Value | $1.1 Billion |
| CAGR | 19.9% |
The beta-farnesene segment accounted for 80.1% share in 2025 and is expected to grow at a CAGR of 20% through 2035. Its strong market position is supported by increasing use in agricultural applications due to its natural origin, biodegradability, and compatibility with sustainable pest management practices. Demand is rising as industries seek bio-based alternatives that reduce reliance on synthetic chemical inputs, while ongoing research continues to expand its use in flavor, fragrance, and energy-related applications.
The fermentation-based production segment held an 85.2% share in 2025 and is projected to grow at a CAGR of 19.9% from 2026 to 2035. This production route is favored for its efficiency and alignment with biotechnology-driven manufacturing, utilizing renewable feedstocks to produce high-purity farnesene suitable for premium applications. The process supports reduced fossil fuel dependence and meets demand for natural-grade ingredients across multiple end-use industries.
North America Farnesene Market held a 27.2% share in 2025. Regional expansion is driven by increasing adoption of sustainable ingredients across personal care and industrial applications, supported by regulatory pressure and consumer demand for environmentally responsible products. Advanced research capabilities and innovation across bio-based chemical manufacturing further contribute to market development.
Key players operating in the Global Farnesene Market include BASF SE, Merck (Sigma-Aldrich), TCI (Tokyo Chemical Industry), Alfa Chemistry, Paraiso Bioenergia, Biosynth, Santa Cruz Biotechnology, LGC Limited, Glentham Life Sciences, Clearsynth, BOC Sciences, and Sigma-aligned specialty chemical suppliers. Companies operating in the Global Farnesene Market are strengthening their market positions by investing in bio-based production technologies and expanding fermentation capacities to ensure scalability and cost efficiency. Strategic collaborations with biotechnology firms and research institutions are helping accelerate product development and application diversification. Many players are prioritizing sustainability-focused branding and regulatory compliance to align with evolving consumer expectations. Geographic expansion into high-growth regions, along with portfolio diversification across industrial, personal care, and pharmaceutical applications, remains a key focus.